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Sumary
Objective: To analyze the perception of empowerment and therapeutic adherence in patients with Type 2 Diabetes and their glycemic 
control in a primary care unit in Tabasco, Mexico.
Materials and methods: Observational, cross-sectional and analytical study in a sample of 100 patients with diabetes. We analyzed 
variables of perception of empowerment, therapeutic adherence, sociodemographic and clinical. As a dependent variable, the figure of 
glycosylated hemoglobin HgA1c was taken as the gold standard of metabolic control. An instrument integrated by the DES-28 scale was 
applied to assess perception of empowerment, a questionnaire to assess the perception of Adherence of Bayarre-Grau. For the analysis, 
descriptive and inferential statistics (Pearson’s X2) were used with the SPSS V22.0 software.
Results: The patients with diabetes were women 72%, average of age 56 years, married 60%, housewives 68%, primary studies 43%, 
average BMI 30.8, average of years with diabetes 8.9, main complication diabetic neuropathy 61% , mean of HgA1 figure of 8.675%, with 
HgA1 figure altered 82%, patients perceived to be empowered were 86%, of these, 80.2% showed lack of control with an x2 of 1,300 and 
a value of p = .000, with adherence 84%, of these patients resulted with altered glycemic control 83.3% with an x2.632 and a value of p = 
.000.
Conclusions: Patients who feel empowered and adherent to treatment in our study have inadequate glycemic control, which allows us 
to conclude that it is necessary to investigate other factors that go beyond perception and an area of opportunity would be to implement 
effective strategies to achieve results successful.
Key words: Type 2 Diabetes mellitus, Self-efficacy, Therapeutic adherence, Glycosylated hemoglobin (HgA1c).
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Resumen
Objetivo: Analizar la percepción de empoderamiento y adherencia terapéutica en pacientes con Diabetes Tipo 2 y su control glucémico en 
una unidad de atención primaria de Tabasco, México.
Mteriales y métodos: Estudio observacional, transversal y analítico, en una muestra de 100 pacientes con diabetes. Se analizaron variables 
de percepción del empoderamiento, adherencia terapéutica, sociodemográficas y clínicas. Como variable dependiente se tomó la cifra de 
Hemoglobina glicosilada HgA1c como estándar de oro del control metabólico. Se aplicó un instrumento integrado por la escala DES-28 
para evaluar percepción del empoderamiento, cuestionario para evaluar percepción de Adherencia de Bayarre-Grau. Para el análisis se 
utilizó estadística descriptiva e inferencial (X2 de Pearson) con el software SPSS V22.0.
Resultados: Los pacientes con diabetes fueron mujeres 72%, media de edad 56 años, casadas 60%, amas de casa 68%, estudios de primaria 
43%, IMC promedio 30.8, promedio de años con diabetes 8.9, principal complicación neuropatía diabética 61%, media de cifra de HgA1 
de 8.675%, con cifra de HgA1 alterada 82%, pacientes que se perciben empoderados fueron 86%, de estos, presentaron descontrol el 80.2% 
con una x2 de 1.300 y un valor de p=.000, con adherencia 84%, de estos pacientes resultaron con un control glucémico alterado el 83.3% 
con una x2 .632 y un valor de p=.000.
Conclusiones: Los pacientes que se perciben empoderados y adherentes al tratamiento en nuestro estudio presentan un control glucémico 
inadecuado, lo que permite concluir que es necesario investigar otros factores que van más allá de la percepción y un área de oportunidad 
sería implementar estrategias efectivas para lograr resultados exitosos.
Palabras clave: Diabetes mellitus Tipo 2, Auto-eficacia, Adherencia Terapéutica, Hemoglobina glicosilada (HgA1c).
Résumé
Objectif: Analyser la perception de l’autonomisation et de l’adhérence thérapeutique chez les patients atteints de diabète de type 2 et leur 
contrôle glycémique dans une unité de soins primaires à Tabasco, au Mexique.
Matériaux et méthodes: Étude observationnelle, transversale et analytique sur un échantillon de 100 patients diabétiques. Nous avons 
analysé des variables de perception de l’autonomisation, de l’adhérence thérapeutique, sociodémographique et clinique. En tant que variable 
dépendante, la valeur de l’hémoglobine glycosylée HgA1c a été prise comme critère de référence du contrôle métabolique. Un instrument 
intégré à l’échelle DES-28 a été utilisé pour évaluer la perception de l’autonomisation, un questionnaire pour évaluer la perception de 
l’adhésion de Bayarre-Grau. Pour l’analyse, des statistiques descriptives et inférentielles (X2 de Pearson) ont été utilisées avec le logiciel 
SPSS V22.0.
Résultats: Les patients diabétiques étaient des femmes 72%, âge moyen 56 ans, marié 60%, les femmes au foyer 68%, l’enseignement 
primaire 43%, IMC moyen de 30,8, la durée moyenne du diabète avec 8,9, complication majeure neuropathie diabétique 61% , chiffre 
moyen de 8,675% hgA1 avec la figure altérée hgA1 82% des patients étaient perçus habilitée 86% de ceux-ci, 80,2% avaient incontrôlée 
avec x2 1300 et une valeur de p = 0,000, avec 84% de ces patients ont présenté un contrôle glycémique altéré de 83,3% avec une valeur de 
x2,632 et une valeur de p = 0,000.
Conclusions: Les patients responsabilisés et adhérents sont perçus à un traitement dans notre étude ont un contrôle glycémique insuffisant, 
ce qui conduit à la conclusion qu’il est nécessaire d’examiner d’autres facteurs qui vont au-delà de la perception et une zone d’opportunité 
serait de mettre en œuvre des stratégies efficaces pour obtenir des résultats réussi.
Mots-clés: Diabète sucré de type 2, auto-efficacité, adhérence thérapeutique, hémoglobine glycosylée (HgA1c).
Resumo
Objetivo: Analisar a percepção da capacitação e da aderência em pacientes com diabetes tipo 2 e controle glicêmico em uma unidade de 
cuidados primários de Tabasco, no México.
Materiais e métodos: Estudo observacional, transversal e analítico em uma amostra de 100 pacientes com diabetes. Foram analisadas 
variáveis de percepção de empoderamento, adesão terapêutica, sociodemográficas e clínicas. À medida que a hemoglobina glicosilada 
HgA1c variável dependente foi feita como ouro controle metabólico padrão. integrado pela escala DES-28 para avaliar a percepção 
da capacitação questionário percepção instrumento para avaliar a adesão Bayarre-Grau aplicada. Para a análise, estatística descritiva e 
inferencial (X2 de Pearson) foram utilizadas com o software SPSS V22.0.
Resultados: Os pacientes com diabetes foram mulheres 72%, idade média de 56 anos, casado 60%, 68% donas de casa, primário 43%, 
IMC médio de 30,8, a média de anos com diabetes 8.9, principal complicação neuropatia diabética 61% , valor médio de 8,675% hgA1 
com figura alterada hgA1 82% dos pacientes com poderes percebidas foram de 86%, destes, 80,2% tinham descontrolada com x2 1.300 e 
um valor de p = 0,000, com adesão de 84% destes pacientes foram alterados com o controlo glicémico com um x2 83,3% 0,632 e p = 0,000
Conclusões: Pacientes com poderes e adeptos são percebidos ao tratamento em nosso estudo têm controle inadequado da glicemia, o que 
leva à conclusão de que é necessário investigar outros fatores que vão além da percepção e uma área de oportunidade seria implementar 
estratégias eficazes para alcançar resultados sucesso
Palavras chave: Diabetes mellitus de tipo 2, a auto-eficácia, aderência Therapeutics, hemoglobina glicada (HgA1c).
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Introduction
Almost 500 million people live with diabetes in the world. 
The president of the International Diabetes Federation 
reported that “diabetes is not just a health crisis,” It is a 
global social catastrophe. It causes devastating personal 
suffering and leads to poverty to families due to its chronic 
nature. Because of the great number of people with diabetes, 
all governments of the world are having troubles to face 
the problems related to diabetes care and this will remain 
a growth cost. As can be seen, the multiple factors related 
to a style of unhealthy life in the population are many and 
they are responsible for the uncontrolled rates of obesity and 
diabetes. 
The problem of diabetes represents a great growing cost 
burden. The IDF has said that by 2017 the total health 
expenditure on diabetes would reach 727 billion dollars 
(people aged 20-79 years with diabetes), which represents 
an increase of 8% compared to the 2015 calculations. When 
using the wide age range group, 18-99, the costs amount to 
850,000 billion dollars. A very high percentage of health 
spending is dedicated to the care of patients with chronic 
diseases; if measures that include therapeutic adherence 
are not taken this numbers will continue to increase, as is 
evident.
Mexico ranks 5th place of the ten territories in the world 
with the highest number of people with diabetes. In 2017, 12 
millions of cases of people aged 20-79 with diabetes were 
registered. According to the FID projections, this problem 
would rank 4th place with an estimate 21.8 million cases in 
2045.
Diabetes causes microvascular and macrovascular 
complications that bring deep psychological and physical 
problems to both patients and caregivers. The incidence and 
prevalence of this disease continues to increase throughout 
the world in spite of growing knowledge about risk factors 
and evidence of prevention programs.
México is one of the most affected countries in Latin America. 
In 2016, an announcement of diabetes epidemiological 
emergency was emitted in the national territory by La 
Secretaría de Salud. According to official data, it represents 
the second leading cause of death with 105, 574 cases in 
2016.
In 2015, in Tabasco, Mexico, type 2 diabetes, one of the 
eleven important causes of death, ranked second place with 
2, 283 cases registered. 
It is in this sense that the need to take urgent measures before 
this health problem is exposed, where the responsibility 
of both the different sectors and the general population is 
joint. The empowerment of the patient in the management 
of his condition is considered as a viable alternative, 
conceptualizing it as the combination of abilities, motivation 
and opportunities of power. Empowerment begins when 
health professionals recognize that patients are in control 
of their daily diabetes care. Today, it is an urgent measure 
giving power to those who have in their hands the decision 
M  - August 
to take care of themselves and adhere to a treatment, and 
should be put into effect. Governments, health systems, non-
governmental organizations and the family are a fundamental 
support in this cause.
Therefore, this study aims to analyze the relationship between 
the level of empowerment and Therapeutic Adherence with 
the glycemic control of patients with Type 2 Diabetes from a 
first level medical unit in Tabasco, Mexico.
Supporting materials and methodology
An observational, transversal and analytical study was 
designed, with the triangulation of the information of the 
applied instruments for deeper analysis. The population 
considered for this study were patients with Type 2 Diabetes 
treated and under treatment in a medical primary care unit 
of Villahermosa, municipality Centro, tabasco, Mexico 
throughout 2016 (N = 286). From the population described, 
the size of the sample was estimated by using the formula to 
obtain a proportion for finite populations, with a reliable data 
of 95% (Z2 = 1.96), a relative error (precision) of 10.0%, 
an estimated prevalence of 50.0%, in a total population of 
N = 286 people. A non-response rate (NRT) of 20.0% was 
considered. The calculated sample was 110 patients (n = 
110), nevertheless, there was a non-response rate of 11.0% 
of the patients to be surveyed, leaving 100 patients to study. 
Simple random probabilistic sampling without replacement 
was performed, based on a census of patients with Type 2 
Diabetes, obtaining n = 100 patients of the indicated universe, 
after selection of the statistical IBM © SPSS © Statistics 
software, 22nd version, and its application of generation 
of numbers random, used for that purpose, where all the 
participants had the same probability of being selected. A 
TNR of 11.0% was presented.
Inclusion criteria, having a diagnosis of Type 2 Diabetes, 
attending consultation to the medical care modules, being 
in treatment during the study period in the morning and 
evening shifts and participating with informed consent were 
considered. Glycemic control (glycosylated hemoglobin 
HgA1c) was the dependent variable; empowerment and 
therapeutic adherence were the variables of interest. 
Sociodemographic and clinical were Secondary or covariable 
variables.
A structured instrument was integrated in order to organize 
the procedures and collect the data for patients with 
Type 2 Diabetes, which included three sections; the first 
section serves for the patients’ identification and their 
sociodemographic, clinical and laboratory data (a clinical, 
methabolic and medical evaluation). The second incorporates 
the DES 28 Scale to measure the perception of the patients’ 
empowerment in their disease and the third one measures 
the therapeutic adherence based on the perception of the 
patients.
The questionnaire was applied and data was obtained from its 
medical, clinical and laboratory records with prior informed 
consent. In order to avoid systematic errors, a training of 
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the personnel in charge of the activity was carried out for 
the correct application of the instrument. Weight and height 
measurements were taken from the medical records and from 
the last visit to his control. Personnel trained in somatometry 
conducted these measurements and the instruments used for 
their measurement were the scales of each medical office, 
carefully calibrated during the procedure. 
A single instrument with four sections was integrated to 
collect the sociodemographic and clinical variables, as well 
as the empowerment and therapeutic adherence:
1. The personal data compilation sheet related to 
sociodemographic, clinical and laboratory information 
included the variables such as age, sex, occupation, marital 
status, schooling, residence, housing, economic dependence 
and metabolic control, as well as evolution time, compliance 
with the treatment installed, among others.
2. The normal glycosylated hemoglobin (HgA1c) was used 
as the gold standard, the results were obtain from the records 
one month prior to the study, for the purpose of determining 
if at the time of the study the patients were in control of their 
blood glucose levels.
3. The DES 28 Scale was used to measure the perception 
of empowerment in patients with diabetes, validated in 
the Hispanic population. A pilot test was conducted for 
the Validation of the scale and its items, as well as the 
verification of the reliability of the instrument using the 
coefficient A. Cronbach that presented a result of .874 for 
the scale, due to the cultural changes and idiosyncrasies of 
the Mexican population of the south-southeast region. The 
degree of empowerment in self-care was determined by 
using a Likert-type scale of 5 points (1= strongly disagree 
to 5= strongly agree). This scale evaluates self-control, self-
efficacy, problem solving, psychosocial coping, support, 
motivation and decision-making.
4. Martín_Bayarre_Grau’s instrument of complementary 
Affirmations was used for the measurement of the perception 
of Adherence in patients, designed to evaluate adherence 
levels and describe their components. It consists of twelve 
items, divided into three factors: personal involvement, 
professional-patient relationship and compliance with 
the treatment, evaluated from the scores obtained in the 
items of the questionnaire. The categories that run through 
the operational definition of therapeutic adherence that 
is proposed were defined as follows: Compliance with 
Treatment (CT); it is the execution by the person of the 
prescribed medical indications, items 1, 2, 3, 4. Implication 
personal (IP); it is the search by the patient of strategies 
to guarantee the fulfillment of the prescriptions with the 
execution of the necessary efforts, items 5, 6, 8, 9 and 10. 
Transactional relationship (RT); this implies the collaboration 
relationship between the patient and his doctor to establish 
the treatment and to elaborate the strategy to follow that 
guarantees compliance and acceptance by both, items 7, 11 
and 12.
Descriptive and inferential statistics were used for the data 
collection and statistical analysis, using the measures of central 
tendency and dispersion and the quantitative, continuous and 
discrete variables. The use of the table of simple frequencies 
with absolute, relative values (percentage) for each category 
of the variables analyzed was considered to analyze the 
qualitative and order qualitative variables. Subsequently, 
the transformation of the dependent variable and continuous 
independent to dichotomous categorical was carried out, 
using as cut-off points the normal and abnormal values of 
each scale and laboratory test used. Bivariate analysis was 
performed between the dependent variable: controlled and 
uncontrolled glycosylated hemoglobin (HbA1c), and the 
main variables, empowerment and therapeutic adherence. 
The application of the Pearson X2 test statistic was 
implemented as well as its degrees of freedom (gl) and the 
value of p≤0.05.
Results
Characterization of the patient with Type 2 Diabetes (T2D), 
according to sociodemographic an biochemical control 
variables
In the studied group, it was observed that patients with 
T2D have a mean age of Ⱦ = 53.58 years, ds ± 11.53 years, 
minimum age of 25 years and maximum of 82 years, range 
of 57, median of 55.58 and mode of 55.50. The variable age 
was recoded in decades; obtaining six categories to compare 
that are shown in table 1, where the following results are 
observed: the decade from 55 to 64 years represented 39.0%, 
the decade from 35 to 44 years, 22.0%. The presence of 
patients aged between 25 and 34 years represented 5.0%, 
classified as T2D should be observed.
According to the prevailing sex, it can be observed that the 
female sex is represented by a 72.0% of the total sample 
analyzed, in terms of the level of studies, elementary and 
middle school patients obtained the highest percentage by 
a 43.0 and 42.0% respectively, those who were married are 
represented by a 60.0% majority and 68.0% to homemakers. 
(Table 1)
According to the place of origin, most patients are from 
urban area and they are represented by an 84.0%; patients 
that live in their own home 76.0%, depend on their spouse 
economically 49.0%, live with a relative 76.0% and live on 
their own 16.0%. (Table 2)
The clinical variables related to the control, treatment and 
complications of Type 2 Diabetes are as shown in (Table 3 
and 4).
Patient going to appointments for metabolic control are 
represented by a 90.0%, those using medications by an 
82.0%, diet and exercise 17.0%. The main complications 
presented were diabetic neuropathy having a 61.0%, other 
white organs such as retinopathy, nephropathy, diabetic foot 
among others, together represent 18.0% and those who have 
no complications 21.0%.
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With regard to comorbidities, arterial hypertension was 
present by a 39.0% of patients; using treatments added to 
DT2 68%, none of them 29.0%, pravastatin 18.0%, captopril 
17.0%, among other antihypertensive drugs. (Table 3)
The average number of years of those patients suffering T2D 
was Ⱦ = 8.96 years, ds ± 7.174 years, having a minimum 
value of 1 year and a maximum of 35,with a range of 34 
years, a median of 7.00 and a mode of 5.0.
The variables of metabolic control and somatometry are 
expressed in table 4. The median of the glucose figure was 
Ⱦ = 152.25mgs / dl, ds ± 53.317mgs / dl, having a minimum 
value of 49mgs / dl and a maximum of 334mgs / dl, with 
a range of 285mgs / dl, an average of 136.0mgs / dl, and a 
mode of 120.0mgs / dl.
The median of the triglycerides figure was Ⱦ = 188.33mgs / 
dl, ds ± 78.530mgs / dl, having a minimum value of 71mgs 
/ dl and a maximum of 652mgs / dl, with a range of 581mgs 
/ dl, a median of 169.0mgs / dl and a mode of 150.0mgs / dl.
The median of the systolic blood pressure figure was Ⱦ = 
121.84mmHg, ds ± 13,848 mmHg, minimum value of 
90mmHg and a maximum of 160mmHg, with a range 
of 70mmHg, a median of 120.0mmHg, and a mode of 
120.0mmHg. The median of the diastolic blood pressure 
figure was Ⱦ = 76.09mmHg, ds ± 8.567mmHg, having a 
minimum value of 60mmHg and a maximum of 90mmHg, 
with a range of 30mmHg, a median of 80.0mmHg and a 
mode of 80.0mmHg.
The median of the weight figure in kilograms of patients with 
T2D was Ⱦ = 73,648 kg, ds ± 15.1143 kg, having a minimum 
value of 46 kg and a maximum of 155.0 kg, with a range of 
109.0 kg, a median of 72,250 kg and a mode of 80.0 kg.
An average size of Ⱦ = 1.5529 m. was presented, with a ds±, 
07809 having a minimum value of 1.37m. and a maximum 
of 174.0 m., with a range of .37cm., a median of 1.5350 m. 
and a mode of 1.50.0 m.
The median of the body mass index (BMI) was Ⱦ = 
30.8194Kg2, ds ± 5.32, having a minimum value of 19.53 
and a maximum of 54.94, with a range of 35.41Kg2, a 
median of 30.79 Kg2 and a mode of 31.20 kg2.
The average abdominal circumference of the patients was Ⱦ 
= 94.06 cm., ds ± 12.219 cm., having a minimum value of 65 
and a maximum value of 140, with a range of 75, a median 
of 96.0 and a mode of 100.
The median of the glycosylated hemoglobin (HbA1c) was Ⱦ 
= 8.07%, ds ± 1.44%, having a minimum value of 4.0%, and 
a maximum value of 12.8%, with a range of 8.8%, a median 
of 8.0% and a mode of 7.5%. According to the percentile, 
25% of patients have HbA1c of 7.2%, 50% have HbA1 of 
8.0%, and of 75% have HbA1c of 8.675%. The continuous 
variable glycosylated hemoglobin (HbA1c) was recorded 
into the normal, uncontrolled and pathological categories 
according to the WHO normative figures. It was observed 
that patients with Type 2 Diabetes under study were found 
with uncontrolled figures of 61.0%, in pathological figures 
they were found with 21.0% and the 18.0% of patients 
were found only with figures of <7.0. Once analyzed the 
outcomes, the variable glycosylated hemoglobin (HbA1c) 
was dichotomized in Normal / Control = 1, when values were 
observed 4.0-6.99 (18.0%) and Abnormal / uncontrolled = 0 
when figures were observed ≥ 7.0-12.99 ( 82.0%). (Table 4).
Level of empowerment of patients with Type 2 Diabetes.
This section describes the results of the analysis of the 
Empowerment instrument questions most frequently 
answered by patients: 1) identify with which actions of their 
health care in T2D is dissatisfied, 57% of them agree. 2). 
He is able to convert his goals into a practical and concrete 
plan of action to control his diabetes, 56% of them agree, 3). 
You can overcome obstacles and achieve your goals for the 
control of your diabetes, 61% of them agree. 4). Find ways 
to feel good even if you have the disease, 54% of them agree. 
5). Know ways to face the stress that causes you to have 
Type 2 Diabetes, 58.0% of them agree. 6). Know where to 
find support to control your disease, 50% of them agree and 
43.0% strongly agree 7) Know what helps you stay motivated 
to control your Type 2 Diabetes, 61% of them agree 8) Know 
enough to make the decisions that are convenient for your 
health care, 53% of them agree.
Empowered patients presented an 86%, and those 
without empowerment revealed a 14%, of the patients with 
empowerment, those who showed lack of control presented the 
80.2% with an x2 of 1,300 and a value of p = .000. (Table 5).
Therapeutic compliance (Bayarre Grau)
In this aspect the 68.0% of patients declared that they always 
take their medication in the established schedule, 72.0% of 
them always take all the indicated doses, 41.0% of them 
always comply with the indications related to the diet, 
36.0% sometimes perform the physical exercises indicated 
in, 72.0% always attend scheduled follow-up visits, 63.0% 
always adjust their medication schedules to their activities 
or daily life, 77.0% of them always decide together with 
their doctor the treatment to follow, 74.0% always comply 
with their treatment without supervision of their family and 
friends, 80.0% always carry out the treatment without making 
great efforts, 51.0% always use reminders that facilitate the 
completion of their treatment, 73.0% always discuss with the 
doctor how to comply the treatment, and 75.0% always have 
the possibility to manifest the acceptance of the treatment 
prescribed by their doctor for their diabetes. The therapeutic 
adherence was present by an 84% of the patients and those 
without adherence were represented by a 16%. The 83.3% 
of the total of patients with adherence resulted uncontrolled 
with x2.632 and a value of p = .000. (Table 5).
Discussion 
This study reveals that patients who feel empowered and 
adherent to treatment have inadequate glycemic control.
Most participants in the study are women (72%), with an 
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Tabla 1. Demographical and social characteristics of patients with type 2 Diabetes,
medical primary health unit no. 1 located in Villahermosa, Tabasco, México, 2016.
Source: Questionnaire.
Tabla 2. Characteristics According to economical and territorial location variables of patients with Type 2 Diabetes, 
medical primary health unit no. 1 located in Villahermosa, Tabasco, México, 2016
Source: Questionnaire.
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Tabla 3. Characteristics according to clinical variables of patients with type 2 Diabetes,
medical primary health unit no. 1 located in Villahermosa, Tabasco, México, 2016.
Source: Questionnaire.
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Tabla 4. Metabolic control and somatometry of patients with T2D,
Medical primary health Unit no. 1 located in Villahermosa
Source: Questionnaire.
Tabla 5. Perception of empowerment and adherence in patients with Type 2 Diabetes,
Medical primary health unit no. 1, 2016
Source: Questionnaire.
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Tabla 6. Perception of empowerment, therapeutic adherence and glycemic control
in patients with type 2 diabetes in a Medical primary health unit in Tabasco, Mexico 2016
average age of 53 (± 11.5) years, a minimum age of 25 
years and a maximum age of 82. The time of evolution with 
diabetes was less than 10 years; these data coincide with that 
observed by Alarcón-Mora and colleagues.
The elementary school level was the predominant scholarship 
in patients, revealing a 43%, and those living with a stable 
partner revealed a 62%. These results are similar to what 
reports Serrani-Azcurra in his study.
Almost all of the participants reported following a 
pharmacological treatment (82%), while glycosylated 
hemoglobin (HbA1c) was found in normal values in 18% 
(4.0-6.99), data differ from that observed by Urban-Reyes 
in its study, with more than 70% of patients with normal 
HbA1c. This could be because they are patients with fewer 
years of evolution with the disease.
The comorbidity that occurs most frequently in patients is 
related to arterial hypertension, similar to that reported by 
Aguilar and Urzúa. The therapeutic adherence reached 
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an 84% in our study, a fact that is similar to that observed 
by Bertoldo et al. and Castillo et al., In which compliance 
behaviors were greater than 60% and 70%, respectively. It 
differs with that said by López-Simarro and collaborators, 
which it could be explained because most of the patients in 
their study were hypertensive.
The patient’s perception of empowerment related to the 
control of their disease is 86%. The literature consulted 
reveals that empowerment is related to a better knowledge 
of diabetes, better adherence and better self-care behaviors.
We will have to work with more effective strategies for 
empowerment to be achieved, such as making a paradigm 
shift, moving from traditional care to patient-centered care, 
without neglecting aspects such as the gender approach in 
health, in this field there is still a significant lag of men who 
do not demand health care in the same proportion as women. 
Dominguez Mont points out in his study that “While the 
tasks of care are considered primarily feminine ... the de-
modernization of health care practices will be little visible”.
Although the instrument explores the perception of 
compliance with the therapy in the patient, it fails to measure 
in more depth determining factors such as type of diet, 
physical activity and other aspects related to their control, 
which could be causing the observed levels of glycosylated 
hemoglobin and other abnormal metabolic control variables.
Investigating other factors and implement empowerment 
strategies are opportunities to achieve successful outcomes.
 
Conclusions
Patients who feel empowered and adherent to the treatment 
have inadequate glycemic control.
Most patients were women, homemakers, with elementary 
schooling, married, in a greater proportion they presented 
obesity, glycosylated hemoglobin and elevated lipids.
Glycemic control is not compatible with the perception of 
empowerment and therapeutic adherence, this is reflected in 
the gold standard figures (glycosylated hemoglobin) and this 
allows researchers to conclude that in their study, patients 
have not really internalized the importance of care and 
responsibility of their health despite having attended their 
medical check-ups for several years.
The patient’s perception of being empowered and being 
adherent in the treatment is not enough to justify the figures of 
glycosylated hemoglobin decontrol presented in this research
Taking a medication-only treatment, the patient’s perception of 
a diet and exercise, is not enough to obtain results that impact 
on the control of their glycosylated hemoglobin, because it is 
not clear how much the patient knows about his diet and also 
it is not clear how much and how he should exercise.
It is recommended to include variables of perception about 
metabolic control, obstacles, challenges, support elements and 
expectations in the patient for further studies.
Implementing effective empowerment strategies would be an 
opportunity to achieve successful outcomes.
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